Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
Aim of the study: evaluate the role of normalization of humoral immunity to address dose reduction or discontinuation of immunosuppressors in patients with autoimmune hepatitis (AIH).Patients and methods. The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to Augu...
Saved in:
Main Authors: | A. O. Bueverov, S. V. Koblov, P. O. Bogomolov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2024-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/920 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in Serum Immunoglobulin Levels Play as Predictors of Treatment Response and Prognosis in Pediatric Idiopathic Nephrotic Syndrome During the Remission Phase
by: Amin sadat Sharif, et al.
Published: (2025-01-01) -
Exploration of rituximab treatment strategies for membranous nephropathy adapted to the Chinese healthcare environment
by: Xiaolong Wang, et al.
Published: (2025-01-01) -
Prognostic value of circulatory growth factors to predict responsiveness to chemotherapy and remission status of patients with acute myeloid leukemia
by: Mohammad Ahmad Bani-Ahmad, et al.
Published: (2024-05-01) -
Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Stošić-Grujičić, et al.
Published: (2001-01-01) -
A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
by: Sabha Mushtaq, et al.
Published: (2024-11-01)